Viewing Study NCT02489695


Ignite Creation Date: 2025-12-24 @ 1:14 PM
Ignite Modification Date: 2026-04-17 @ 10:31 PM
Study NCT ID: NCT02489695
Status: COMPLETED
Last Update Posted: 2022-09-06
First Post: 2015-06-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma
Sponsor: Centre Leon Berard
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module